1-1 of 1
Tilman Bostel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interferon Alpha 2a (IFN) Maintenance Therapy After Imatinib Plus IFN Induction Therapy in Chronic Myeloid Leukemia (CML) Induces Stable Long-Term Molecular Remissions and Is Associated with Increased Proteinase 3 (PR3) Expression and the Presence of PR1-Specific T-Cells.

Andreas Burchert, MD, Martin C Müller, MD, Philippe Kostrewa, med., Philipp Erben, MD, Tilman Bostel, MD, Simone Liebler, MD, Rüdiger Hehlmann, MD, Andreas Neubauer, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2009) 114 (22): 647.
https://doi.org/10.1182/blood.V114.22.647.647
Published: 2009